Early Detection Research Network

http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/229/263/sensitivity-data-1

15
95
0
Phase II results for early-stage cases compared with general population controls by sensitivity at 95% specificity. From Table 3, "Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens", Cancer Prev Res (Phila). 2011 Mar;4(3):365-74